Kinnate Biopharma

Acquired

Clinical-stage precision oncology company.

Kinnate Biopharma is a biotech company in San Diego, United States, founded in 2018. It has raised $146.0M across 2 rounds, most recently a $98.0M Series C in August 2020.

Headquarters
San Diego
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$146.0M
Last Round
$98.0M Series CAug 2020
Rounds
2
Acquired by
XOMAJan 2024

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. to use credits for reveals, or explore the API.

About

Kinnate Biopharma was a clinical-stage precision oncology company based in San Diego, California, founded in 2018, that designed small-molecule kinase inhibitors targeting oncogenic drivers such as RAF and FGFR for patients whose cancers had progressed on prior therapies. The company went public on Nasdaq in 2020, cut 70% of its workforce in a September 2023 restructuring, sold its lead pan-RAF program exarafenib to Pierre Fabre Laboratories in March 2024, and was acquired by XOMA Corporation the same year, ending independent operations.

Funding & Exit History

Data from Indexed.vcUpdated
Acquisition2024 (est.)

3 more events

  • IPO2020
  • Series C2020
  • Series A2019

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • DevOps ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kinnate Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/kinnate-biopharma"><img src="https://indexed.vc/api/badge/company/kinnate-biopharma" alt="Kinnate Biopharma on Indexed.vc" width="260" height="76" /></a>